St. Jude Research

2017 Archive

Families affected by childhood cancer and sickle cell disease honored during September
Families affected by childhood cancer and sickle cell disease honored during September
Outreach

Families affected by childhood cancer and sickle cell disease honored during September

 Janice English, RN

St. Jude honors its patients, survivors and their families during the month of September and every day. Watch the video.

Childhood Solid Tumor Network shares samples, promotes cures
Childhood Solid Tumor Network shares samples, promotes cures
Research

Childhood Solid Tumor Network shares samples, promotes cures

 Michael Dyer, PhD

The CSTN provides the world’s largest collection of pediatric cancerous tumors for research into novel treatments. Find out more about available resources.

New CAR T-Cell therapy for pediatric ALL approved, more to come
New CAR T-Cell therapy for pediatric ALL approved, more to come
Research

New CAR T-Cell therapy for pediatric ALL approved, more to come

 Stephen Gottschalk, MD

The FDA has approved Kymriah, the first CAR T-cell therapy for acute lymphoblastic leukemia. Find out how St. Jude is planning to use this novel treatment.

Becoming the best pediatric cancer hospital for our patients
Becoming the best pediatric cancer hospital for our patients
Clinical

Becoming the best pediatric cancer hospital for our patients

 James R. Downing, MD

Find out what makes St. Jude Children’s Research Hospital the best pediatric cancer hospital in the nation.

Can ESCRT-III proteins protect cells from necroptosis?
Can ESCRT-III proteins protect cells from necroptosis?
Research

Cell necroptosis: Can ESCRT-III proteins protect cells from the kill switch?

 Douglas R. Green, PhD

Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.

Epigenetic mapping leads to developmental insights into retinoblastoma
Epigenetic mapping leads to developmental insights into retinoblastoma
Research

Cracking the epigenetic code of retinoblastoma

 Michael Dyer, PhD

St. Jude scientists, in work published in the journal Neuron, used powerful analytical tools to map what is known as the “epigenetics” of the retina.

Uncovering the body’s immune system response
Uncovering the body’s immune system response
Research

Discovering new molecular switches to control autoinflammatory disease

 Thirumala-Devi Kanneganti, PhD

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

Yoga rehab helps pineoblastoma patient regain strength, coordination
Yoga rehab helps pineoblastoma patient regain strength, coordination
Clinical

Yoga rehab helps pineoblastoma patient regain strength, coordination

 Keith Crabtree, PhD

Find out how Trinity uses yoga and make-believe creatures to regain her strength and coordination after pineoblastoma, a type of childhood cancer.

Advice for new graduates from a pediatric oncologist - St. Jude Progress
Advice for new graduates from a pediatric oncologist - St. Jude Progress
Outreach

Advice for new graduates from a pediatric oncologist

 Ching-Hon Pui, MD

Ching-Hon Pui, MD, shares how he became a leading pediatric leukemia researcher. He has advice for those pursuing their dreams.

Latin American clinicians attend Global Pediatric Cancer course
Latin American clinicians attend Global Pediatric Cancer course
Outreach

Latin American clinicians attend global medicine course

 Mike O’Kelly

The St. Jude Global program hosted clinicians from 17 Latin American countries to enhance the quality of pediatric cancer care around the world.